Research ArticleAccepted Article
Whole Blood Targeted Bisulfite Sequencing Validates Differential Methylation in C6ORF10 gene of Patients with Rheumatoid Arthritis
Vidyanand Anaparti, Prasoon Agarwal, Irene Smolik, Neeloffer Mookherjee and Hani Elgabalawy
The Journal of Rheumatology November 2019, jrheum.190376; DOI: https://doi.org/10.3899/jrheum.190376
Vidyanand Anaparti
Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg,; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg; Departments of Internal Medicine & Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada. The study was supported by individual grants to Dr. Hani El-Gabalawy from the Canadian Institute of Health Research (CIHR). V. Anaparti received postdoctoral fellowships from Research Manitoba and Arthritis Society of Canada. Corresponding & submitting author: Vidyanand Anaparti, PhD, Department of Internal Medicine, University of Manitoba, Room 799, 715 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 3P4 Email – Vidyanand.Anaparti@umanitoba.ca
Prasoon Agarwal
Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg,; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg; Departments of Internal Medicine & Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada. The study was supported by individual grants to Dr. Hani El-Gabalawy from the Canadian Institute of Health Research (CIHR). V. Anaparti received postdoctoral fellowships from Research Manitoba and Arthritis Society of Canada. Corresponding & submitting author: Vidyanand Anaparti, PhD, Department of Internal Medicine, University of Manitoba, Room 799, 715 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 3P4 Email – Vidyanand.Anaparti@umanitoba.ca
Irene Smolik
Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg,; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg; Departments of Internal Medicine & Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada. The study was supported by individual grants to Dr. Hani El-Gabalawy from the Canadian Institute of Health Research (CIHR). V. Anaparti received postdoctoral fellowships from Research Manitoba and Arthritis Society of Canada. Corresponding & submitting author: Vidyanand Anaparti, PhD, Department of Internal Medicine, University of Manitoba, Room 799, 715 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 3P4 Email – Vidyanand.Anaparti@umanitoba.ca
Neeloffer Mookherjee
Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg,; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg; Departments of Internal Medicine & Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada. The study was supported by individual grants to Dr. Hani El-Gabalawy from the Canadian Institute of Health Research (CIHR). V. Anaparti received postdoctoral fellowships from Research Manitoba and Arthritis Society of Canada. Corresponding & submitting author: Vidyanand Anaparti, PhD, Department of Internal Medicine, University of Manitoba, Room 799, 715 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 3P4 Email – Vidyanand.Anaparti@umanitoba.ca
Hani Elgabalawy
Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg,; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg; Departments of Internal Medicine & Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada. The study was supported by individual grants to Dr. Hani El-Gabalawy from the Canadian Institute of Health Research (CIHR). V. Anaparti received postdoctoral fellowships from Research Manitoba and Arthritis Society of Canada. Corresponding & submitting author: Vidyanand Anaparti, PhD, Department of Internal Medicine, University of Manitoba, Room 799, 715 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 3P4 Email – Vidyanand.Anaparti@umanitoba.ca
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Whole Blood Targeted Bisulfite Sequencing Validates Differential Methylation in C6ORF10 gene of Patients with Rheumatoid Arthritis
Vidyanand Anaparti, Prasoon Agarwal, Irene Smolik, Neeloffer Mookherjee, Hani Elgabalawy
The Journal of Rheumatology Nov 2019, jrheum.190376; DOI: 10.3899/jrheum.190376
Accepted manuscript
Whole Blood Targeted Bisulfite Sequencing Validates Differential Methylation in C6ORF10 gene of Patients with Rheumatoid Arthritis
Vidyanand Anaparti, Prasoon Agarwal, Irene Smolik, Neeloffer Mookherjee, Hani Elgabalawy
The Journal of Rheumatology Nov 2019, jrheum.190376; DOI: 10.3899/jrheum.190376